Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Synergy Pharmaceuticals, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Amendment No. 1 to the Registration Statement on Form S-3 of our report dated April 15, 2009, relating to the consolidated financial statements, of Synergy Pharmaceuticals, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO Seidman, LLP |
New York, New York |
|
December 7, 2009 |
